Utkarsh Small Finance Bank Ltd
₹11.74
-0.42 (3.45%)
Fri, 06 Nov 2026, 10:03 pm
Utkarsh Small Finance Bank News
Utkarsh SFB Q2FY27 loss narrows to ₹69.85 lakh
Utkarsh Small Finance Bank reported a net loss of ₹69.85 lakh for Q2FY27, a significant improvement from ₹34.85 crore loss in Q2FY26. NII grew 14% YoY.
03 Nov 2026
companies
Utkarsh Small Finance Bank Q2FY27 business update
Utkarsh Small Finance Bank reported Q2FY27 business updates with total disbursements rising 54.9% YoY to ₹3,525 crore and gross loan portfolio growing 7.5% YoY to ₹20,063 crore.
06 Oct 2026
companies
Utkarsh SFB sells stressed loans worth ₹75.16 Cr
Utkarsh Small Finance Bank approved the sale of a stressed unsecured loan pool with ₹75.16 crore principal outstanding for ₹15.50 crore to an NBFC.
30 Sept 2026
companies
Utkarsh SFB allots ₹300 crore Tier II bonds
Utkarsh Small Finance Bank allotted ₹300 crore in subordinated NCDs at an 11.75% coupon rate on a private placement basis to strengthen capital.
25 Sept 2026
debt-markets
Utkarsh SFB appoints Manmohan Shetty as CFO
Utkarsh Small Finance Bank has appointed Manmohan Shetty as Chief Financial Officer and Key Managerial Personnel effective September 19, 2026, following Board approval.
19 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo